The global Multiple Sclerosis Treatment Market is anticipated to grow at a CAGR of 5.8%, reaching USD 44.45 billion by 2034, driven by innovation.

Neuraxpharm highlights its dedication to multiple sclerosis treatment at ECTRIMS 2025 in Barcelona, showcasing innovative therapies in CNS disorders.

In a groundbreaking partnership, Neurophet collaborates with VHIR to enhance AI diagnoses for multiple sclerosis, employing advanced MRI analysis for improved patient outcomes.

The Multiple Sclerosis Association of America proudly announces Amanda Montague as its new President and CEO. Her leadership is set to enhance services for the MS community.

Century Health and Nira Medical team up to enhance multiple sclerosis patient care through AI-curated electronic health records for improved treatment outcomes.

Immunic, Inc. to present new findings from the Phase 2 CALLIPER trial of Vidofludimus Calcium at the upcoming ACTRIMS Forum 2026, emphasizing its potential in treating progressive multiple sclerosis.

Shakira Hussein, a mother of eight-year-old Adalya, faced a life-altering diagnosis of relapsing-remitting multiple sclerosis (MS) that gradually eroded her fine motor skills and ability to play the violin. Initially dismissing her symptoms as fatigue or stress, she eventually self-diagnosed with MS after severe neurological decline. Though treatments brought remission, permanent damage left her unable to perform complex musical pieces or ride a bike. Determined to keep music alive, she shifted from violin to tabla, embracing its forgiving nature for those with dexterity challenges. Despite never playing the Bach double with her daughter as planned, they now explore new musical combinations. The article highlights resilience in overcoming MS-related limitations while maintaining familial and artistic connections, showcasing how adaptability can preserve cherished traditions.

The Multiple Sclerosis Association of America celebrates a decade of its online forum, My MSAA Community, providing vital support to those impacted by MS.

Immunic, Inc. shares insights into its financial outcomes and executive changes while highlighting its ongoing clinical trials for MS treatments.

The NHS in England has approved the use of Fampridine, a drug that aids individuals with multiple sclerosis (MS) in improving their mobility. This medication works by enhancing nerve signals, enabling better movement and independence. Aysen Slack, a patient who previously paid privately for the drug due to its high cost, welcomed the decision as it would significantly improve her quality of life. Up to 5,000 people in England could benefit annually from this treatment, which is already available in other UK regions. MS occurs when the immune system attacks myelin, damaging nerve pathways and impairing muscle control. Clinical trials showed that around 40% of patients experienced improved walking speed and endurance. NHS officials emphasized that even modest improvements can enhance daily living, such as independent movement within homes or greater confidence in social settings. Eligibility is based on the severity of walking difficulties, with patients required to demonstrate clear benefits after a month of treatment. Experts highlighted the drug's potential to transform lives, allowing individuals to maintain independence and remain employed.

The National Multiple Sclerosis Society has announced RKD Group as its official fundraising agency, aiming for enhanced donor engagement.

Combined treatment with #metformin and #clemastine may promote #myelin repair in people with #multiple_sclerosis, according to data presented at #ECTRIMS2025. https://ow.ly/FsnE50X85bp National MS So...

Independent rapper B-Cide has livestreamed on TikTok for over 270 days, building an international community focused on resilience, music, and genuine conversation.

Advanced Neurology of Colorado unveils its new comprehensive MS center in Lone Tree, enhancing patient access to specialized neurological care.

The MSAA has successfully expanded its MS Implementation Network, enrolling over 1,000 participants across 20 locations to improve care for MS patients.

Through the sponsorship of Bike MS event, U.S. Money Reserve aims to advance research and support for individuals affected by multiple sclerosis.

Join the Multiple Sclerosis Association of America on May 7, 2026, for their 12th Improving Lives Benefit, supporting the MS community with in-person and online attendance options.

The Mendoza Family, including Heisman winner Fernando Mendoza, has launched a new fund with the National MS Society to combat multiple sclerosis and support families.

LifeQuotes.com announced its findings on the most competitive life insurance rates for Multiple Sclerosis patients in 2026, providing hope for over 1 million individuals.

March is MS Awareness Month and the MSAA launches a campaign focusing on self-advocacy strategies, fostering cooperation between patients and healthcare providers.

A recent study unveils the potential of wearable device data to monitor disease progression in multiple sclerosis patients, featured in the Journal of Neuroimmunology.

A recent study confirms that NB-UVB phototherapy significantly reduces inflammation in multiple sclerosis patients, highlighting its therapeutic potential beyond dermatological use.